STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.

Tao Zeng, Jianzhong Ye, Heng Wang, Wen Tian

Medicine 2023 Apr 25

filter terms:

Renal clear cell carcinoma (KIRC) is a malignancy of the renal epithelial cells with poor prognosis. Notably, the JAK-STAT pathway mediates cell proliferation and immune response. Accumulating evidence suggests that STATs act as immune checkpoint inhibitors in various cancers. Nonetheless, the role of STAT2 in KIRC remains elusive. Herein, analyses were performed using a series of interactive web databases including Oncomine, GEPIA and TIMER. In sub-group analyses, STAT2 was upregulated at both the mRNA and protein levels in KIRC patients. Besides, KIRC patients with high STAT2 expression exhibited a poor overall survival. Moreover, Cox regression analysis revealed that STAT2 expression, nodal metastasis and clinical stage were independent factors affecting the prognosis of KIRC patients. There was a significant positive correlation between STAT2 expression, and the abundance of immune cells as well as the expression of immune biomarker sets. In addition, STAT2 was found to be implicated in immune response, cytokine-cytokine receptor interaction, and Toll-like receptor signaling pathways. Also, several cancer-related kinases, miRNAs, and transcription factors associated with STAT2 were identified. Conclusively, we revealed that STAT2 is a potential prognosis biomarker and associated with immune infiltration in kidney renal clear cell carcinoma. This study offers additional data that will help in further research on the roles of STAT2 protein in carcinogenesis. Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Citation

Tao Zeng, Jianzhong Ye, Heng Wang, Wen Tian. STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma. Medicine. 2023 Apr 25;102(17):e33662